Structure Database (LMSD)
| LM_ID | Common Name | Systematic Name | Main Class | Sub Class | Mass | Formula |
|---|---|---|---|---|---|---|
| LMFA01030749 | 5,14,15-trihydroxy-6,8,10,12-Eicosatetraenoic acid | 5,14,15-trihydroxy-6,8,10,12-Eicosatetraenoic acid | Fatty Acids and Conjugates [FA01] | Unsaturated fatty acids [FA0103] | 352.22 | C20H32O5 |
| LMFA03000035 | 8,9-11,12-diepoxy-13-hydroxyeicosadienoic acid | 8,9;11,12-diepoxy-13R-hydroxy-5Z,14Z-eicosadienoic acid | Eicosanoids [FA03] | - | 352.22 | C20H32O5 |
| LMFA03000030 | - | 14S,17R,18R-trihydroxy-5Z,8Z,11Z,15E-eicosatetraenoic acid | Eicosanoids [FA03] | - | 352.22 | C20H32O5 |
| LMFA03000032 | - | 16S17S,18R-trihydroxy-5Z,8Z,11Z,14Z-eicosatetraenoic acid | Eicosanoids [FA03] | - | 352.22 | C20H32O5 |
| LMFA03000031 | - | 16R,17S,18R-trihydroxy-5Z,8Z,11Z,14Z-eicosatetraenoic acid | Eicosanoids [FA03] | - | 352.22 | C20H32O5 |
| LMFA03010060 | 11beta-PGE2 | 9-oxo-11S,15S-dihydroxy-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 352.22 | C20H32O5 |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 11,15-dioxo-9S-hydroxy-5Z-prostenoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 352.22 | C20H32O5 |
| LMFA03010031 | 13,14-dihydro-15-keto-PGE2 | 9,15-dioxo-11R-hydroxy-5Z-prostenoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 352.22 | C20H32O5 |
| LMFA03010146 | 15-keto-PGE1 | 9,15-dioxo-11R-hydroxy-13E-prostaenoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 352.22 | C20H32O5 |
| LMFA03010026 | 15-keto-PGF2alpha | 9S,11R-dihydroxy-15-oxo-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 352.22 | C20H32O5 |
| LMFA03010102 | 15R-PGD2 | 9S,15R-dihydroxy-11-oxo-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 352.22 | C20H32O5 |
| LMFA03010094 | 15R-PGE2 | 9-oxo-11R,15R-dihydroxy-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 352.22 | C20H32O5 |
| LMFA03010148 | 5-trans-PGE2 | 9-oxo-11R,15S-dihydroxy-5E,13E-prostadienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 352.22 | C20H32O5 |
| LMFA03010143 | D17 PGE1 | 9-oxo-11R,15S-dihydroxy-13E,17Z-prostadienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 352.22 | C20H32O5 |
| LMFA03010101 | delta-12-PGD2 | 9S,15S-dihydroxy-11-oxo-5Z,12E-prostadienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 352.22 | C20H32O5 |
| LMFA03010004 | PGD2 | 9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 352.22 | C20H32O5 |
| LMFA03010003 | PGE2 | 9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 352.22 | C20H32O5 |
| LMFA03010138 | PGF3alpha | 9S,11R,15S-trihydroxy-5Z,13E,17Z-prostatrienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 352.22 | C20H32O5 |
| LMFA03010010 | PGH2 | 9S,11R-epidioxy-15S-hydroxy-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 352.22 | C20H32O5 |
| LMFA03010087 | PGI2 | 6,9S-epoxy-11R,15S-dihydroxy-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 352.22 | C20H32O5 |
| LMFA03010170 | PGK1 | 9,11-dioxo-15S-hydroxy-13E-prostenoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 352.22 | C20H32O5 |
| LMFA03020018 | 20-hydroxy LTB4 | 5S,12R,20-trihydroxy-6Z,8E,10E,14Z-eicosatetraenoic acid | Eicosanoids [FA03] | Leukotrienes [FA0302] | 352.22 | C20H32O5 |
| LMFA03030001 | TXA2 | 9S,11S-epoxy,15S-hydroxy-thromboxa-5Z,13E-dien-1-oic acid | Eicosanoids [FA03] | Thromboxanes [FA0303] | 352.22 | C20H32O5 |
| LMFA03040008 | 13,14-dihydro-15-keto-LXA4 | 15-oxo-5S,6R-dihydroxy-7E,9E,11Z-eicosatrienoic acid | Eicosanoids [FA03] | Lipoxins [FA0304] | 352.22 | C20H32O5 |
| LMFA03040010 | 15-epi-lipoxin A4 | (5S,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid | Eicosanoids [FA03] | Lipoxins [FA0304] | 352.22 | C20H32O5 |
| LMFA03040003 | epi-Lipoxin A4 | 5S,6S,15S-trihydroxy-7E,9E,11Z,13E-eicosatetraenoic acid | Eicosanoids [FA03] | Lipoxins [FA0304] | 352.22 | C20H32O5 |
| LMFA03040007 | epi-Lipoxin B4 | 5S,14R,15R-trihydroxy-6E,8Z,10E,12E-eicosatetraenoic acid | Eicosanoids [FA03] | Lipoxins [FA0304] | 352.22 | C20H32O5 |
| LMFA03040001 | Lipoxin A4 | 5S,6R,15S-trihydroxy-7E,9E,11Z,13E-eicosatetraenoic acid | Eicosanoids [FA03] | Lipoxins [FA0304] | 352.22 | C20H32O5 |
| LMFA03040002 | Lipoxin B4 | 5S,14R,15S-trihydroxy-6E,8Z,10E,12E-eicosatetraenoic acid | Eicosanoids [FA03] | Lipoxins [FA0304] | 352.22 | C20H32O5 |
| LMFA03050025 | 13,14-Dihydro-15-oxo-lipoxin A4 | (5R,6R,7E,9E,11Z)-5,6-dihydroxy-15-oxoicosa-7,9,11-trienoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosatrienoic acids [FA0305] | 352.22 | C20H32O5 |
| LMFA03000029 | - | 14R,17R,18R-trihydroxy-5Z,8Z,11Z,15E-eicosatetraenoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosatetraenoic acids [FA0306] | 352.22 | C20H32O5 |
| LMFA03100025 | 12-epi-12-iso-LGD2 | (5S,9R)-6,7-seco-6,8-dioxo-12R-hydroxy-10E,14Z-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100009 | 12-epi-12-iso-LGE2 | (5S,9R)-7,8-seco-6,8-dioxo-12R-hydroxy-10E,14Z-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100028 | 12-iso-LGD2 | (5S,9R)-6,7-seco-6,8-dioxo-12S-hydroxy-10E,14Z-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100012 | 12-iso-LGE2 | (5S,9R)-7,8-seco-6,8-dioxo-12S-hydroxy-10E,14Z-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100021 | 15-epi-15-iso-LGD2 | (8S,12R)-9,10-seco-9,11-dioxo-15R-hydroxy-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100005 | 15-epi-15-iso-LGE2 | (8S,12R)-10,11-seco-9,11-dioxo-15R-hydroxy-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100024 | 15-iso-LGD2 | (8S,12R)-9,10-seco-9,11-dioxo-15S-hydroxy-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100008 | 15-iso-LGE2 | (8S,12R)-10,11-seco-9,11-dioxo-15S-hydroxy-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100033 | 5-epi-5-iso-LGD2 | (8S,12R)-9,10-seco-9,11-dioxo-5R-hydroxy-6E,14Z-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100017 | 5-epi-5-iso-LGE2 | (8S,12R)-10,11-seco-9,11-dioxo-5R-hydroxy-6E,14Z-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100036 | 5-iso-LGD2 | (8S,12R)-9,10-seco-9,11-dioxo-5S-hydroxy-6E,14Z-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100020 | 5-iso-LGE2 | (8S,12R)-10,11-seco-9,11-dioxo-5S-hydroxy-6E,14Z-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100029 | 8-epi-8-iso-LGD2 | (11S,15R)-12,13-seco-12,14-dioxo-8R-hydroxy-5Z,9E-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100013 | 8-epi-8-iso-LGE2 | (11S,15R)-13,14-seco-12,14-dioxo-8R-hydroxy-5Z,9E-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100032 | 8-iso-LGD2 | (11S,15R)-12,13-seco-12,14-dioxo-8S-hydroxy-5Z,9E-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100016 | 8-iso-LGE2 | (11S,15R)-13,14-seco-12,14-dioxo-8S-hydroxy-5Z,9E-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100026 | ent-12-epi-12-iso-LGD2 | (5R,9S)-6,7-seco-6,8-dioxo-12S-hydroxy-10E,14Z-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100010 | ent-12-epi-12-iso-LGE2 | (5R,9S)-7,8-seco-6,8-dioxo-12S-hydroxy-10E,14Z-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100027 | ent-12-iso-LGD2 | (5R,9S)-6,7-seco-6,8-dioxo-12R-hydroxy-10E,14Z-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100011 | ent-12-iso-LGE2 | (5R,9S)-7,8-seco-6,8-dioxo-12R-hydroxy-10E,14Z-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100022 | ent-15-epi-15-iso-LGD2 | (8R,12S)-9,10-seco-9,11-dioxo-15S-hydroxy-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100006 | ent-15-epi-15-iso-LGE2 | (8R,12S)-10,11-seco-9,11-dioxo-15S-hydroxy-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100023 | ent-15-iso-LGD2 | (8R,12S)-9,10-seco-9,11-dioxo-15R-hydroxy-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100007 | ent-15-iso-LGE2 | (8R,12S)-10,11-seco-9,11-dioxo-15R-hydroxy-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100034 | ent-5-epi-5-iso-LGD2 | (8R,12S)-9,10-seco-9,11-dioxo-5S-hydroxy-6E,14Z-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100018 | ent-5-epi-5-iso-LGE2 | (8R,12S)-10,11-seco-9,11-dioxo-5S-hydroxy-6E,14Z-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100035 | ent-5-iso-LGD2 | (8R,12S)-9,10-seco-9,11-dioxo-5R-hydroxy-6E,14Z-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100019 | ent-5-iso-LGE2 | (8R,12S)-10,11-seco-9,11-dioxo-5R-hydroxy-6E,14Z-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100030 | ent-8-epi-8-iso-LGD2 | (11R,15S)-12,13-seco-12,14-dioxo-8S-hydroxy-5Z,9E-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100014 | ent-8-epi-8-iso-LGE2 | (11R,15S)-13,14-seco-12,14-dioxo-8S-hydroxy-5Z,9E-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100031 | ent-8-iso-LGD2 | (11R,15S)-12,13-seco-12,14-dioxo-8R-hydroxy-5Z,9E-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100015 | ent-8-iso-LGE2 | (11R,15S)-13,14-seco-12,14-dioxo-8R-hydroxy-5Z,9E-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100003 | isoLGD2 | 9,10-seco-9,11-dioxo-15-hydroxy-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100004 | isoLGE2 | 10,11-seco-9,11-dioxo-15-hydroxy-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100002 | LGD2 | (8R,12R)-9,10-seco-9,11-dioxo-15S-hydroxy-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03100001 | LGE2 | (8R,12R)-10,11-seco-9,11-dioxo-15S-hydroxy-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Levuglandins [FA0310] | 352.22 | C20H32O5 |
| LMFA03110221 | 11-epi-8-D2c-IsoP | (S,5Z,9E)-8-hydroxy-10-((1S,2S,5S)-5-hydroxy-3-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110222 | 11-epi-8-D2t-IsoP | (S,5Z,9E)-8-hydroxy-10-((1R,2R,5S)-5-hydroxy-3-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110212 | 11-epi-8-E2c-IsoP | (S,5Z,9E)-8-hydroxy-10-((1S,2S,3R)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110211 | 11-epi-8-E2t-IsoP | (S,5Z,9E)-8-hydroxy-10-((1R,2R,3R)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110079 | 12-D2c-IsoP | 6S,12S-dihydroxy-8-oxo-10E,14Z-prostadienoic acid-cyclo[5R,9S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110085 | 12-D2t-IsoP | 6S,12S-dihydroxy-8-oxo-10E,14Z-prostadienoic acid-cyclo[5S,9R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110189 | 12-E2c-IsoP | 4-((1R,2S,3R)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110190 | 12-E2t-IsoP | 4-((1S,2R,3R)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110080 | 12-epi-12-D2c-IsoP | 6S,12R-dihydroxy-8-oxo-10E,14Z-prostadienoic acid-cyclo[5R,9S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110084 | 12-epi-12-D2t-IsoP | 6S,12R-dihydroxy-8-oxo-10E,14Z-prostadienoic acid-cyclo[5S,9R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110187 | 12-epi-12-E2c-IsoP | 4-((1R,2S,3R)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110188 | 12-epi-12-E2t-IsoP | 4-((1S,2R,3R)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110093 | 15-D2c-IsoP | 9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid-cyclo[8R,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110099 | 15-D2t-IsoP | 9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid-cyclo[8S,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110126 | 15-E2c-IsoP | 9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8R,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110094 | 15-epi-15-D2c-IsoP | 9S,15R-dihydroxy-11-oxo-5Z,13E-prostadienoic acid-cyclo[8R,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110098 | 15-epi-15-D2t-IsoP | 9S,15R-dihydroxy-11-oxo-5Z,13E-prostadienoic acid-cyclo[8S,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110124 | 15-epi-15-E2c-IsoP | 9-oxo-11R,15R-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8R,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110125 | 15-epi-15-E2t-IsoP | 9-oxo-11R,15R-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8S,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110239 | 5,12-diepi-12-D2c-IsoP | 4-((1S,2S,5S)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-3-oxocyclopentyl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110240 | 5,12-diepi-12-D2t-IsoP | 4-((1R,2R,5S)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-3-oxocyclopentyl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110191 | 5,12-diepi-12-E2c-IsoP | 4-((1S,2S,3R)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110192 | 5,12-diepi-12-E2t-IsoP | 4-((1R,2R,3R)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110231 | 5,8-diepi-5-D2c-IsoP | (R,E)-5-hydroxy-7-((1S,2S,5S)-5-hydroxy-2-((Z)-oct-2-en-1-yl)-3-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110232 | 5,8-diepi-5-D2t-IsoP | (R,E)-5-hydroxy-7-((1R,2R,5S)-5-hydroxy-2-((Z)-oct-2-en-1-yl)-3-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110065 | 5-D2c-IsoP | 5S,9S-dihydroxy-11-oxo-6E,14Z-prostadienoic acid-cyclo[8R,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110070 | 5-D2t-IsoP | 5S,9S-dihydroxy-11-oxo-6E,14Z-prostadienoic acid-cyclo[8S,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110173 | 5-E2c-IsoP | (S,E)-5-hydroxy-7-((1R,2S,3R)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110174 | 5-E2t-IsoP | (S,E)-5-hydroxy-7-((1S,2R,3R)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110237 | 5-epi-12-D2c-IsoP | 4-((1S,2S,5S)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-3-oxocyclopentyl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110238 | 5-epi-12-D2t-IsoP | 4-((1R,2R,5S)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-3-oxocyclopentyl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110193 | 5-epi-12-E2c-IsoP | 4-((1S,2S,3R)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110194 | 5-epi-12-E2t-IsoP | 4-((1R,2R,3R)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110066 | 5-epi-5-D2c-IsoP | 5R,9S-dihydroxy-11-oxo-6E,14Z-prostadienoic acid-cyclo[8R,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110069 | 5-epi-5-D2t-IsoP | 5R,9S-dihydroxy-11-oxo-6E,14Z-prostadienoic acid-cyclo[8S,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110171 | 5-epi-5-E2c-IsoP | (R,E)-5-hydroxy-7-((1R,2S,3R)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110172 | 5-epi-5-E2t-IsoP | (R,E)-5-hydroxy-7-((1S,2R,3R)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110223 | 8,11-diepi-8-D2c-IsoP | (R,5Z,9E)-8-hydroxy-10-((1S,2S,5S)-5-hydroxy-3-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110224 | 8,11-diepi-8-D2t-IsoP | (R,5Z,9E)-8-hydroxy-10-((1R,2R,5S)-5-hydroxy-3-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110216 | 8,11-diepi-8-E2c-IsoP | (R,5Z,9E)-8-hydroxy-10-((1S,2S,3R)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110215 | 8,11-diepi-8-E2t-IsoP | (R,5Z,9E)-8-hydroxy-10-((1R,2R,3R)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110131 | 8,15-diepi-15-D2c-IsoP | 11-oxo-9S,15R-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8S,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110175 | 8,5-diepi-5-E2c-IsoP | (R,E)-5-hydroxy-7-((1S,2S,3R)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110176 | 8,5-diepi-5-E2t-IsoP | (R,E)-5-hydroxy-7-((1R,2R,3R)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110051 | 8-D2c-IsoP | 8S,12S-dihydroxy-14-oxo-5Z,9E-prostadienoic acid-cyclo[11R,15S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110057 | 8-D2t-IsoP | 8S,12S-dihydroxy-14-oxo-5Z,9E-prostadienoic acid-cyclo[11S,15R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110214 | 8-E2c-IsoP | (S,5Z,9E)-8-hydroxy-10-((1R,2S,3R)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110213 | 8-E2t-IsoP | (S,5Z,9E)-8-hydroxy-10-((1S,2R,3R)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110132 | 8-epi-15-D2c-IsoP | 11-oxo-9S,15S-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8S,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110127 | 8-epi-15-E2c-IsoP | 9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8S,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110229 | 8-epi-5-D2c-IsoP | (S,E)-5-hydroxy-7-((1S,2S,5S)-5-hydroxy-2-((Z)-oct-2-en-1-yl)-3-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110230 | 8-epi-5-D2t-IsoP | (S,E)-5-hydroxy-7-((1R,2R,5S)-5-hydroxy-2-((Z)-oct-2-en-1-yl)-3-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110177 | 8-epi-5-E2c-IsoP | (S,E)-5-hydroxy-7-((1S,2S,3R)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110178 | 8-epi-5-E2t-IsoP | (S,E)-5-hydroxy-7-((1R,2R,3R)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110052 | 8-epi-8-D2c-IsoP | 8R,12S-dihydroxy-14-oxo-5Z,9E-prostadienoic acid-cyclo[11R,15S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110056 | 8-epi-8-D2t-IsoP | 8R,12S-dihydroxy-14-oxo-5Z,9E-prostadienoic acid-cyclo[11S,15R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110218 | 8-epi-8-E2c-IsoP | (R,5Z,9E)-8-hydroxy-10-((1R,2S,3R)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110217 | 8-epi-8-E2t-IsoP | (R,5Z,9E)-8-hydroxy-10-((1S,2R,3R)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110005 | 8-iso-15-keto-PGF2alpha | 9S,11R-dihydroxy-15-oxo-5Z,13E-prostadienoic acid-cyclo[8S,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110003 | 8-iso-PGE2 | 9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8S,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110007 | 8-iso-PGF3alpha | 9S,11R,15S-trihydroxy-5Z,13E,17Z-prostatrienoic acid-cyclo[8S,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110225 | ent-11-epi-8-D2c-IsoP | (R,5Z,9E)-8-hydroxy-10-((1R,2R,5R)-5-hydroxy-3-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110226 | ent-11-epi-8-D2t-IsoP | (R,5Z,9E)-8-hydroxy-10-((1S,2S,5R)-5-hydroxy-3-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110204 | ent-11-epi-8-E2c-IsoP | (R,5Z,9E)-8-hydroxy-10-((1R,2R,3S)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110203 | ent-11-epi-8-E2t-IsoP | (R,5Z,9E)-8-hydroxy-10-((1S,2S,3S)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110078 | ent-12-D2c-IsoP | 6R,12R-dihydroxy-8-oxo-10E,14Z-prostadienoic acid-cyclo[5S,9R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110083 | ent-12-D2t-IsoP | 6R,12R-dihydroxy-8-oxo-10E,14Z-prostadienoic acid-cyclo[5R,9S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110197 | ent-12-E2c-IsoP | 4-((1S,2R,3S)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110198 | ent-12-E2t-IsoP | 4-((1R,2S,3S)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110081 | ent-12-epi-12-D2c-IsoP | 6R,12S-dihydroxy-8-oxo-10E,14Z-prostadienoic acid-cyclo[5S,9R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110082 | ent-12-epi-12-D2t-IsoP | 6R,12S-dihydroxy-8-oxo-10E,14Z-prostadienoic acid-cyclo[5R,9S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110195 | ent-12-epi-12-E2c-IsoP | 4-((1S,2R,3S)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110196 | ent-12-epi-12-E2t-IsoP | 4-((1R,2S,3S)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110092 | ent-15-D2c-IsoP | 9R,15R-dihydroxy-11-oxo-5Z,13E-prostadienoic acid-cyclo[8S,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110097 | ent-15-D2t-IsoP | 9R,15R-dihydroxy-11-oxo-5Z,13E-prostadienoic acid-cyclo[8R,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110117 | ent-15-E2c-IsoP | 9-oxo-11S,15R-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8S,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110116 | ent-15-E2t-IsoP | 9-oxo-11S,15R-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8R,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110095 | ent-15-epi-15-D2c-IsoP | 9R,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid-cyclo[8S,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110096 | ent-15-epi-15-D2t-IsoP | 9R,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid-cyclo[8R,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110121 | ent-15-epi-15-E2c-IsoP | 9-oxo-11S,15S-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8S,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110120 | ent-15-epi-15-E2t-IsoP | 9-oxo-11S,15S-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8R,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110243 | ent-5,12-diepi-12-D2c-IsoP | 4-((1R,2R,5R)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-3-oxocyclopentyl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110244 | ent-5,12-diepi-12-D2t-IsoP | 4-((1S,2S,5R)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-3-oxocyclopentyl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110199 | ent-5,12-diepi-12-E2c-IsoP | 4-((1R,2R,3S)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110200 | ent-5,12-diepi-12-E2t-IsoP | 4-((1S,2S,3S)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110235 | ent-5,8-diepi-5-D2c-IsoP | (S,E)-5-hydroxy-7-((1R,2R,5R)-5-hydroxy-2-((Z)-oct-2-en-1-yl)-3-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110236 | ent-5,8-diepi-5-D2t-IsoP | (S,E)-5-hydroxy-7-((1S,2S,5R)-5-hydroxy-2-((Z)-oct-2-en-1-yl)-3-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110064 | ent-5-D2c-IsoP | 5R,9R-dihydroxy-11-oxo-6E,14Z-prostadienoic acid-cyclo[8S,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110077 | ent-5-D2t-IsoP | 5R,9R-dihydroxy-11-oxo-6E,14Z-prostadienoic acid-cyclo[8R,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110181 | ent-5-E2c-IsoP | (R,E)-5-hydroxy-7-((1S,2R,3S)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110182 | ent-5-E2t-IsoP | (R,E)-5-hydroxy-7-((1R,2S,3S)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110241 | ent-5-epi-12-D2c-IsoP | 4-((1R,2R,5R)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-3-oxocyclopentyl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110242 | ent-5-epi-12-D2t-IsoP | 4-((1S,2S,5R)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-3-oxocyclopentyl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110201 | ent-5-epi-12-E2c-IsoP | 4-((1R,2R,3S)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110202 | ent-5-epi-12-E2t-IsoP | 4-((1S,2S,3S)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110067 | ent-5-epi-5-D2c-IsoP | 5S,9R-dihydroxy-11-oxo-6E,14Z-prostadienoic acid-cyclo[8S,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110068 | ent-5-epi-5-D2t-IsoP | 5S,9R-dihydroxy-11-oxo-6E,14Z-prostadienoic acid-cyclo[8R,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110179 | ent-5-epi-5-E2c-IsoP | (S,E)-5-hydroxy-7-((1S,2R,3S)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110180 | ent-5-epi-5-E2t-IsoP | (S,E)-5-hydroxy-7-((1R,2S,3S)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110227 | ent-8,11-diepi-8-D2c-IsoP | (S,5Z,9E)-8-hydroxy-10-((1R,2R,5R)-5-hydroxy-3-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110228 | ent-8,11-diepi-8-D2t-IsoP | (S,5Z,9E)-8-hydroxy-10-((1S,2S,5R)-5-hydroxy-3-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110208 | ent-8,11-diepi-8-E2c-IsoP | (S,5Z,9E)-8-hydroxy-10-((1R,2R,3S)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110207 | ent-8,11-diepi-8-E2t-IsoP | (S,5Z,9E)-8-hydroxy-10-((1S,2S,3S)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110129 | ent-8,15-diepi-15-D2c-IsoP | 11-oxo-9R,15S-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8R,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110130 | ent-8,15-diepi-15-D2t-IsoP | 11-oxo-9R,15S-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8S,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110122 | ent-8,15-diepi-15-E2t-IsoP | 9-oxo-11S,15S-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8S,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110183 | ent-8,5-diepi-5-E2c-IsoP | (S,E)-5-hydroxy-7-((1R,2R,3S)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110184 | ent-8,5-diepi-5-E2t-IsoP | (S,E)-5-hydroxy-7-((1S,2S,3S)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110050 | ent-8-D2c-IsoP | 8R,12R-dihydroxy-14-oxo-5Z,9E-prostadienoic acid-cyclo[11S,15R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110055 | ent-8-D2t-IsoP | 8R,12R-dihydroxy-14-oxo-5Z,9E-prostadienoic acid-cyclo[11R,15S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110206 | ent-8-E2c-IsoP | (R,5Z,9E)-8-hydroxy-10-((1S,2R,3S)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110205 | ent-8-E2t-IsoP | (R,5Z,9E)-8-hydroxy-10-((1R,2S,3S)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110128 | ent-8-epi-15-D2c-IsoP | 11-oxo-9R,15R-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8R,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110115 | ent-8-epi-15-E2c-IsoP | 9-oxo-11S,15R-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8R,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110233 | ent-8-epi-5-D2c-IsoP | (R,E)-5-hydroxy-7-((1R,2R,5R)-5-hydroxy-2-((Z)-oct-2-en-1-yl)-3-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110234 | ent-8-epi-5-D2t-IsoP | (R,E)-5-hydroxy-7-((1S,2S,5R)-5-hydroxy-2-((Z)-oct-2-en-1-yl)-3-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110185 | ent-8-epi-5-E2c-IsoP | (R,E)-5-hydroxy-7-((1R,2R,3S)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110186 | ent-8-epi-5-E2t-IsoP | (R,E)-5-hydroxy-7-((1S,2S,3S)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110053 | ent-8-epi-8-D2c-IsoP | 8S,12R-dihydroxy-14-oxo-5Z,9E-prostadienoic acid-cyclo[11S,15R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110054 | ent-8-epi-8-D2t-IsoP | 8S,12R-dihydroxy-14-oxo-5Z,9E-prostadienoic acid-cyclo[11R,15S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110210 | ent-8-epi-8-E2c-IsoP | (S,5Z,9E)-8-hydroxy-10-((1S,2R,3S)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110209 | ent-8-epi-8-E2t-IsoP | (S,5Z,9E)-8-hydroxy-10-((1R,2S,3S)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110107 | ent-PGD2 | 9R,15R-dihydroxy-11-oxo-5Z,13E-prostadienoic acid-cyclo[8S,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03110106 | ent-PGE2 | 9-oxo-11S,15R-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8S,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 352.22 | C20H32O5 |
| LMFA03140001 | 10,11-dihydro-Resolvin E1 | 5S,12,18S-trihydroxy-6Z,8E,14Z,16E-eicosatetraenoic acid | Eicosanoids [FA03] | - | 352.22 | C20H32O5 |
| LMFA03150002 | 15R-hydroxy-12S,14R-dioxolane-5Z,8Z,10E-eicosatrienoic acid | 15R-hydroxy-12S,14R-dioxolane-5Z,8Z,10E-eicosatrienoic acid | Eicosanoids [FA03] | - | 352.22 | C20H32O5 |
| LMFA04000106 | Ectocarpin D | (5E,8E,11E)-12-{(1'R,2'S,3'S,5'S)-2',3'-dihydroxy-5'-[(1''R)-1''-hydroxypropyl]cyclopentyl}-5,8,11-dodecatrienoic acid | Docosanoids [FA04] | - | 352.22 | C20H32O5 |
Download LMSD record summary for FA 20:4;O3